CDKN2A and oropharynx cancer: Investigating the descriptive statistics of the new TNM8 group, p16 positive oropharyngeal cancer patients were younger than p16 negative OPSCC or other HNSCC groups with mean ages 58, 63 and 63 years at diagnosis, respectively.